This announcement is a separate document:
澳優：(1)有關海普諾凱生物科技收購事項之 股份及關連交易； (2)有關海普諾凱收購事項之 須予披露及關連交易之條款修訂； 及 (3)股東特別大會通告
AUSNUTRIA: (1) SHARE AND CONNECTED TRANSACTION REGARDING THE HBC ACQUISITION; (2) AMENDMENTS OF TERMS OF DISCLOSEABLE AND CONNECTED TRANSACTION REGARDING THE HNC ACQUISITION; AND (3) NOTICE OF EGM
Jul 10, 2020 16:32
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.